65+ years: 4.8% per 8.98 ppb (2.3-7.4%) per 8.98 in 65+ years ppb (). () 1-hour maximum Lag 01 Meta-analysis of 5 cities - Brisbane, Canberra, Melbourne, Perth, Sydney. Low heterogeneity. lCD9: 410; ICDI0: I21, I22 Respiratory 65+ years: 1.0016 No effect n/a n/a n/a Recommended (1.0006-1.0026) per () Consistent evidence CRF: 1 ppb (), Pooled CRF from of positive 1-4 years: 3.6% Pooled estimate 5 cities. associations. (1.5-5.7%) per 9.0 from 4 cities - () ppb; 5-14 years: Sydney, Perth, 2.5% (95%CI not 4.0% (1.1-7.1%) per Melbourne, available) per 10 9.0 ppb; 15-64 Brisbane. ug/m3 years: 1.6% lCD9: 460-519 () per 9.0 ppb ICDI0: J00-J99 () (). (excluding ICD9: 460-519 R09.1, 65+ years: 1.0016 R09.8 (1.0006-1.0026) per 1-hour maximum 1 ppb () 1-4 years: 3.6% (1.5-5.7%) per 9.0 ppb 5-14 years: 4.0%
65+ years: 4.8% (2.3-7.4%) per 8.98 ppb () 1-hour maximum Lag 01 Meta-analysis of 5 cities - Brisbane, Canberra, Melbourne, Perth, Sydney. Low heterogeneity. lCD9: 410; ICDI0: I21, I22 per 8.98 ppb in 65+ years (). Respiratory 65+ years: 1.0016 (1.0006-1.0026) per 1 ppb Pooled estimate from 4 cities - Sydney, Perth, Melbourne, Brisbane. lCD9: 460-519 ICDI0: J00-J99 (excluding R09.1, R09.8 1-hour maximum 1-4 years: 3.6% (1.5-5.7%) per 9.0 ppb 5-14 years: 4.0% No effect () (), Pooled CRF from 5 cities. 2.5% (95%CI not available) per 10 ug/m3 () () ICD9: 460-519 n/a n/a Consistent evidence of positive associations. () n/a Recommended CRF: 1-4 years: 3.6% (1.5-5.7%) per 9.0 ppb; 5-14 years: 4.0% (1.1-7.1%) per 9.0 ppb; 15-64 years: 1.6% per 9.0 ppb (). 65+ years: 1.0016 (1.0006-1.0026) per 1 ppb ()
health-report.docx